MYH11 and gastric cancer: In this study, a relationship was substantiated between MYH11 downregulation and the hypermethylation of its promoter in GC, and poorly expressed MYH11 was correlated with a poor prognosis and was intimately intertwined with tumor size, TNM stage, and lymph node metastasis of GC patients.